Publication:
Characterisation of Legionella Clinical Isolates in Spain from 2012 to 2022

dc.contributor.authorGonzález-Rubio, Juana María
dc.contributor.authorCascajero Díaz, Almudena
dc.contributor.authorBaladron-Jimenez, Beatriz Isabel
dc.contributor.authorGonzalez-Camacho, Fernando
dc.contributor.funderInstituto de Salud Carlos IIIes_ES
dc.date.accessioned2024-07-01T09:56:37Z
dc.date.available2024-07-01T09:56:37Z
dc.date.issued2024-06
dc.description.abstractAlthough cases of Legionnaires’ disease are notifiable, data on the phenotypic and genotypic characterisation of clinical isolates are limited. This retrospective study aims to report the results of the characterisation of Legionella clinical isolates in Spain from 2012 to 2022. Monoclonal antibodies from the Dresden panel were used for phenotypic identification of Legionella pneumophila. Genotypic characterisation and sequence type assignment were performed using the Sequence-Based Typing scheme. Of the 1184 samples, 569 were identified as Legionella by culture. Of these, 561 were identified as L. pneumophila, of which 521 were serogroup 1. The most common subgroups were Philadelphia (n = 107) and Knoxville (n = 106). The SBT analysis revealed 130 different STs, with the most common genotypes being ST1 (n = 87), ST23 (n = 57), ST20 (n = 30), and ST42 (n = 29). Knoxville has the highest variability with 32 different STs. ST23 is mainly found in Allentown/France (n = 46) and ST42 in Benidorm (n = 18), whereas ST1 is widely distributed. The results demonstrate that clinical isolates show high genetic diversity, although only a few sequence types (STs) are responsible for most cases. However, outbreaks can also occur with rare genotypes. More data on LD and associated epidemiological studies are needed to establish the risk of an isolate causing outbreak in the future.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipThe APC was funded by Instituto de Salud Carlos III [AESI-2022 MPY 341/22 project to F.G.C.].es_ES
dc.format.number7es_ES
dc.format.page1253es_ES
dc.format.volume12es_ES
dc.identifier.citationMicroorganisms. 2024; 12(7):1253.es_ES
dc.identifier.doi10.3390/microorganisms12071253es_ES
dc.identifier.e-issn2076-2607es_ES
dc.identifier.journalMicroorganismses_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/19885
dc.language.isoenges_ES
dc.publisherMultidisciplinary Digital Publishing Institute (MDPI)es_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/MPY341/22es_ES
dc.relation.publisherversionhttps://doi.org/10.3390/microorganisms12071253es_ES
dc.repisalud.centroISCIII::Centro Nacional de Microbiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAtribución 4.0 Internacional
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectLegionellaes_ES
dc.subjectLegionnaires’ diseasees_ES
dc.subjectClinical isolateses_ES
dc.subjectSequence-based typinges_ES
dc.subjectOutbreakses_ES
dc.subjectPublic Healthes_ES
dc.titleCharacterisation of Legionella Clinical Isolates in Spain from 2012 to 2022es_ES
dc.typeresearch articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublication5c3bb6d2-1678-45d5-85fd-b088c1c4ccb9
relation.isAuthorOfPublication0054c742-0072-491b-9f65-05a4f4ddcd7b
relation.isAuthorOfPublication16ca30ec-854c-4770-931e-e7d9ea71369a
relation.isAuthorOfPublicationae7e52c4-61ca-4e4e-bd39-6051922e30ef
relation.isAuthorOfPublication.latestForDiscovery5c3bb6d2-1678-45d5-85fd-b088c1c4ccb9

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
CharacterisationLegionellaClinicalIsolates_2024.pdf
Size:
1.67 MB
Format:
Adobe Portable Document Format
Description: